Mohindru Mani 4
4 · Cara Therapeutics, Inc. · Filed Mar 15, 2019
Insider Transaction Report
Form 4
Mohindru Mani
CFO & Chief Strategy Officer
Transactions
- Exercise/Conversion
Common Stock
2019-03-13$14.06/sh+16,041$225,536→ 24,067 total - Sale
Common Stock
2019-03-13$19.12/sh−16,041$306,704→ 8,026 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-03-13−16,041→ 336,875 totalExercise: $14.06Exp: 2027-08-15→ Common Stock (16,041 underlying)
Footnotes (2)
- [F1]This exercise and corresponding sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 7, 2018.
- [F2]One-fourth (1/4th) of the 385,000 shares subject to this option vested and became exercisable on August 15, 2018; the balance of the shares shall vest and become exercisable in a series of 36 successive equal monthly installments measured from August 15, 2018, subject to the reporting person's continuous service with the issuer as of each such date.